Sabra (SBRA) Reports Q4 Earnings: What Key Metrics Have to Say

Core Insights - Sabra Healthcare (SBRA) reported revenue of $182.35 million for Q4 2024, marking an 11.6% year-over-year increase, with EPS of $0.36 compared to $0.07 a year ago [1] - The reported revenue fell slightly short of the Zacks Consensus Estimate of $183.22 million, resulting in a surprise of -0.48%, while the EPS met the consensus estimate [1] Revenue Breakdown - Interest and other income amounted to $9.41 million, slightly below the average estimate of $9.71 million, reflecting a year-over-year increase of 3.4% [4] - Resident fees and services generated $76.87 million, exceeding the estimated $75.05 million, representing a significant year-over-year increase of 25.5% [4] - Rental and related revenues were reported at $96.07 million, slightly below the average estimate of $96.34 million, with a year-over-year change of 3.3% [4] Stock Performance - Over the past month, Sabra's shares have returned -3.5%, contrasting with the Zacks S&P 500 composite's increase of 2.4% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]